Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer
-
Indonesia Energy Corporation Commences Drilling of K-29 Well
-
US Defense Manufacturer, Elmet Technologies, to Streamline Supply Chain for Rapid Production of Hypersonic Vehicle Parts with 3D Systems DMP Flex 350 Triple
-
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
-
Bombardier Celebrates 200th Delivery of its Challenger 3500 Jet to Mr. Piero Ferrari as Super-Midsize Category Leading Momentum Continues
-
Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut
-
Ponce Financial Group, Inc. Reports Second Quarter 2026 Results
-
Webinar - presentation of the financial results of Liven AS for 6 months and Q1 of 2026
-
Costamare Inc. Reports Results for the Second Quarter and Six-Month Period Ended June 30, 2026
-
Keel Infrastructure Schedules Second Quarter 2026 Conference Call on August 10, 2026
-
HBT Financial, Inc. Announces Second Quarter 2026 Financial Results
-
Belo Sun Announces Final Resolution of Civil Public Action
-
Prospect Enhanced Yield Fund Announces Dividend Increase to 11.5% Annualized Rate
-
Lakeland Financial Reports Record Second Quarter Performance; Net Income Increases 5% to $28.4 million on 7% Revenue Expansion; Average Loans Grow by 6%
-
Picard Medical Receives NYSE American Acceptance of Compliance Plan
-
Union Power Metals Confirms Upcoming Drill Program at Slovakia Manganese Projects
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Americold and Feed the Children Celebrate 10 Years of Helping Families Access Food and Essential Resources
-
Legence Sets Second Quarter 2026 Earnings Release Date and Webcast Schedule
-
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
-
Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations
-
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
-
Argo Closes $10 Million Strategic Investment
-
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
-
Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations
-
Luckin Coffee to Announce Second Quarter 2026 Financial Results on August 3, 2026
-
Wetour Robotics to Enter into Warehouse Robotics Cooperation Agreement; Management Estimates Full Contemplated Rollout Could Generate Approximately US$5.0 Million in Project-Level Gross Profit
-
Cielo Announces Executive Changes and Stock Option Grants
-
XPO Appoints Michael Kneeland to Board of Directors
-
Expand Energy Corporation to Acquire Twin Eagle, Creating North America’s Leading Integrated Natural Gas Company
-
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
-
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
-
PPHC to Report Second Quarter 2026 Financial Results and Present at Upcoming Investor Conference
-
Troilus Selected by the Government of Quebec to Receive Specialized Support Through the New Filon Initiative for Strategic Mining Projects
-
Dmitry Shubov Consulting Issues Strategic Analysis on Capital-Efficient Delaware Flip Models for Southeast Asian Scale-Ups
-
Legence Sets Second Quarter 2026 Earnings Release Date and Webcast Schedule
-
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
-
Vanguard Food Announces Corporate Rebrand to Verdexa Holdings
-
Baker Hughes Secures Major LNG Technology Order for Venture Global’s CP2 LNG Expansion
-
Marex Group Limited to announce second quarter 2026 results on August 12, 2026
-
VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb
-
Fury Resumes Activities at Eau Claire
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
-
InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
-
Novo Nordisk A/S - share repurchase programme
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
W&T Offshore Announces Timing of Second Quarter 2026 Earnings Release and Conference Call
-
SPX Announces Appointment of New Board Member
-
Vireo Growth Inc. to Acquire Planet 13 Holdings Inc.
